Trexquant Investment’s Kyntra Bio KYNB Stock Holding History

Trexquant Investment’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,801	Closed	-$840K	–	1541
2023 Q1	$840K	Buy	+1,801	New	+$953K	0.02%	803
2022 Q1	–	Sell	-778	Closed	-$274K	–	1467
2021 Q4	$274K	Sell	778 -956	-55%	-$298K	0.02%	977
2021 Q3	$443K	Buy	+1,734	New	+$614K	0.04%	586
2020 Q4	–	Sell	-915	Closed	-$941K	–	1166
2020 Q3	$941K	Buy	+915	New	+$985K	0.06%	440
2019 Q2	–	Sell	-672	Closed	-$913K	–	913
2019 Q1	$913K	Buy	+672	New	+$911K	0.06%	423
2018 Q4	–	Sell	-133	Closed	-$201K	–	1106
2018 Q3	$201K	Buy	+133	New	+$205K	0.02%	822
2018 Q1	–	Sell	-767	Closed	-$909K	–	1173
2017 Q4	$909K	Buy	+767	New	+$962K	0.1%	320
2017 Q3	–	Sell	-278	Closed	-$224K	–	856
2017 Q2	$224K	Sell	278 -141	-34%	-$98.2K	0.06%	614
2017 Q1	$258K	Sell	419 -851	-67%	-$518K	0.03%	837
2016 Q4	$679K	Buy	+1,270	New	+$634K	0.11%	314
2016 Q1	–	Sell	-1,044	Closed	-$795K	–	993
2015 Q4	$795K	Buy	+1,044	New	+$693K	0.07%	488

Other funds holding KYNB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Trexquant Investment's KYNB Position: Q2 2023 in Review

Trexquant Investment sold out of Kyntra Bio (KYNB) in Q2 2023, closing a stake of 1,801 shares — an estimated $840K sold.

Trexquant Investment first reported a position in KYNB in Q4 2015 and held it in 11 quarters. The position peaked at $941K in Q3 2020. 152 funds tracked by Wall St. Rank hold KYNB as of Q2 2023.

Trexquant Investment reported no remaining Kyntra Bio position as of Q2 2023 after selling out during the quarter.
Trexquant Investment sold 1,801 Kyntra Bio shares in Q2 2023, an estimated $840K.
Trexquant Investment first reported a position in Kyntra Bio in Q4 2015 and held it in 11 quarters.
Trexquant Investment's Kyntra Bio position peaked at $941K in Q3 2020.
152 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2023.

Based on Trexquant Investment's 13F filing for Q2 2023, filed 11 Aug 2023.